Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer

Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer

Neoadjuvant therapy has been widely employed in the treatment of rectal cancer, demonstrating its utility in reducing tumor volume, downstaging tumors, and improving patient prognosis. It has become the standard preoperative treatment modality for locally advanced rectal cancer. However, the efficac...

Full description

Bibliographic Details
Main Authors:	Guilin Yu, Huanyu Chi, Guohua Zhao, Yue Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Oncology
Subjects:	rectal tumor neoadjuvant therapy distal resection margin tumor regression safe distance
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1375334/full

Similar Items

Investigation into the effect of neoadjuvant therapy and tumor regression grade on the shrinkage of distal surgical margin in rectal cancer: A prospective case-control study
by: Ulaş Aday, et al.
Published: (2022-01-01)

Multimodality treatment in patients with operable distal rectal cancer
by: Yu. A. Barsukov, et al.
Published: (2015-02-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

Rectal cancer with severe distal spreading
by: A. A. Nevolskikh, et al.
Published: (2012-09-01)

Effect of Neoadjuvant Treatment on TRG, Surgical Complications and LARS in Patients with Rectal Cancer
by: CHEN Gongqin, et al.
Published: (2021-12-01)

Association of levels of metabolites with the safe margin of rectal cancer surgery: a metabolomics study
by: Shaopeng Zhang, et al.
Published: (2022-10-01)

Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer
by: Lucian Dragoș Bratu, et al.
Published: (2024-04-01)

Significance of Nutritional-Inflammatory Index as Predictors for Total Neoadjuvant Therapy-Induced Tumor Regression in Locally Advanced Rectal Cancer Patients
by: Zhao Z, et al.
Published: (2024-06-01)

Influencing factors and establishment of a prediction model for the tumor regression after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: LIU Zhiyu, XU Dong, CHEN Xihao, LI Jipeng
Published: (2024-02-01)

Measurement of distal intramural spread and the optimal distal resection by naked eyes after neoadjuvant radiation for rectal cancers
by: Ge Sun, et al.
Published: (2022-09-01)

Pattern of Residual Submucosal Involvement after Neoadjuvant Therapy for Rectal Cancer: A Rationale for the Utility of Endoscopic Submucosal Resection
by: Haidy Elazzamy, et al.
Published: (2023-10-01)

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01)

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER
by: S. R. Altybaev, et al.
Published: (2016-11-01)

Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
by: Dea Natalie Munch Jepsen, et al.
Published: (2022-01-01)

Clinical feasibility of the therapeutic strategies total neoadjuvant therapy and “watch and wait” in the treatment of rectal cancer patients with recurrence after clinical complete response
by: Dianyin Dai, et al.
Published: (2023-01-01)

Analysis of risk factors for positive circumferential resection margin in rectal cancer
by: ZHU Congcong, ZHENG Hongtu, XU Ye
Published: (2020-11-01)

Prognostic Value of Tumor Regression Grade Combined with Pathological Lymph Node Status in Initially Node-Positive Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Dakui Luo, et al.
Published: (2025-01-01)

A modified method for precise anastomosis during laparoscopic low anterior resection for rectal cancer: the first clinical experience and application
by: Bobo Zheng, et al.
Published: (2024-02-01)

Transanal Total Mesorectal Excision for Rectal Cancer: Toward Standardization of the Surgical Technique
by: Daichi Kitaguchi, et al.
Published: (2023-10-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Prognostic impact of tumor budding in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis
by: Jinghui Li, et al.
Published: (2024-01-01)

Impact of consolidation chemotherapy in poor responders to neoadjuvant radiation therapy: magnetic resonance imaging–based clinical-radiological correlation in high-risk rectal cancers
by: Swapnil Patel, et al.
Published: (2023-12-01)

Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population‐based retrospective study
by: Qi Liu, et al.
Published: (2018-08-01)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-04-01)

Laparoscopic extralevator abdominoperineal excision in distal rectal cancer patients: a retrospective comparative study
by: Zhiqiang Wang, et al.
Published: (2022-12-01)

Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
by: Stefan D. van der Stel, et al.
Published: (2023-09-01)

Effects of Neoadjuvant Chemio-Radiation Therapy on the Anal Sphincter Function in Patients with Low Rectal Cancers
by: A. B. Baichorov, et al.
Published: (2020-11-01)

The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy
by: Jianguo Yang, et al.
Published: (2024-02-01)

Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer
by: Hongyan Huang, et al.
Published: (2023-10-01)

Active surveillance in long period of total neoadjuvant therapy in rectal cancer: Early prediction of poor regression response
by: Haoyu Zhang, et al.
Published: (2022-11-01)

A Simple Intraoperative Technique for Restoring Rotational and Length Alignment After Distal Femur Resection and Endoprosthesis Reconstruction: A Technical Note
by: Ramy Samargandi, MD, et al.
Published: (2024-02-01)

Transvaginal Excision of Rectal Gastrointestinal Stromal Tumor: A Safe Minimally Invasive Approach
by: Hadiel Kaiyasah, et al.
Published: (2021-11-01)

What are the most important prognostic factors in patients with residual rectal cancer after preoperative chemoradiotherapy?
by: Sol-Min Kim, et al.
Published: (2019-05-01)

Is there a relation between the changes in circulating lymphocyte counts due to neoadjuvant chemoradiotherapy and intratumoral lymphocytic response and tumor regression grade in locally advanced rectal cancers?
by: Necdet Fatih Yasar, et al.
Published: (2017-12-01)

Recent advance in neoadjuvant chemotherapy for rectal cancer
by: GUO Yang, GUO Tian′an, XU Ye
Published: (2022-07-01)

Neoadjuvant therapy for locally advanced rectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

Risk factors of positive resection margin differ in pancreaticoduodenectomy and distal pancreatosplenectomy for pancreatic ductal adenocarcinoma undergoing upfront surgery
by: Bo Li, et al.
Published: (2023-04-01)

Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy
by: Linda Kokaine, et al.
Published: (2021-09-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)

Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
by: Madison L. Conces, et al.
Published: (2024-01-01)